CENPH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.151400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.083200E-01
Normal-vs-Stage2
8.641000E-01
Normal-vs-Stage3
6.323000E-01
Normal-vs-Stage4
5.224800E-01
Stage1-vs-Stage2
5.576200E-01
Stage1-vs-Stage3
6.578200E-01
Stage1-vs-Stage4
5.215600E-01
Stage2-vs-Stage3
3.709600E-01
Stage2-vs-Stage4
3.249000E-01
Stage3-vs-Stage4
9.258400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.615200E-01
Normal-vs-AfricanAmerican
5.441000E-01
Normal-vs-Asian
7.734000E-01
Caucasian-vs-AfricanAmerican
3.178000E-01
Caucasian-vs-Asian
5.362200E-02
AfricanAmerican-vs-Asian
6.360200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.637200E-01
Normal-vs-Female
8.578200E-01
Male-vs-Female
5.816400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.435800E-01
Normal-vs-Age(41-60Yrs)
8.511400E-01
Normal-vs-Age(61-80Yrs)
9.943600E-01
Normal-vs-Age(81-100Yrs)
4.809400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.620180E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.120600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.051830E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.098600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.727820E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.913700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.254800E-01
Normal-vs-Daily Drinker
5.870400E-01
Normal-vs-Weekly Drinker
9.464400E-01
Normal-vs-Occasional Drinker
7.648000E-01
Normal-vs-Social Drinker
8.181600E-01
Non Drinker-vs-Daily Drinker
4.253400E-01
Non Drinker-vs-Weekly Drinker
7.615800E-01
Non Drinker-vs-Occasional Drinker
7.744200E-01
Non Drinker-vs-Social Drinker
7.752800E-01
Daily Drinker-vs-Weekly Drinker
3.099200E-01
Daily Drinker-vs-Occasional Drinker
5.840400E-01
Daily Drinker-vs-Social Drinker
7.012400E-01
Weekly Drinker-vs-Occasional Drinker
5.599800E-01
Weekly Drinker-vs-Social Drinker
6.163600E-01
Occasional Drinker-vs-Social Drinker
9.611600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.813200E-01
Normal-vs-Grade 2
7.658600E-01
Normal-vs-Grade 3
8.113800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.506240E-02
Grade 1-vs-Grade 3
6.800600E-03
Grade 1-vs-Grade 4
6.813200E-01
Grade 2-vs-Grade 3
2.796000E-01
Grade 2-vs-Grade 4
7.658600E-01
Grade 3-vs-Grade 4
8.113800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.472800E-01
Normal-vs-NonDiabetic
8.928600E-01
Diabetic-vs-NonDiabetic
8.800200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.163000E-01
Normal-vs-NoPancreatitis
9.222400E-01
Pancreatitis-vs-NoPancreatitis
4.822600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.411800E-01
Normal-vs-N1
9.492200E-01
N0-vs-N1
2.973400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.724200E-01
Normal-vs-TP53-NonMutant
9.239600E-01
TP53-Mutant-vs-TP53-NonMutant
3.104800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
